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ABSTRACT 
Flavone apigenin is a plant bioactive 
compound abundantly found in human diets. 
Apigenin has antioxidant, anti-inflammatory and 
anti-carcinogenic activities, thereby presenting 
promising yet unexploited prospects for the 
prevention and treatment of various 
inflammatory diseases. Apigenin, like other 
flavones, naturally occurs in plants in its glycoside 
form. However, apigenin glycosides are less 
absorbed compared to their aglycone 
counterparts leading to diminished anti-
inflammatory and anti-cancer activities in in vitro 
and in vivo models. Additionally, apigenin 
aglycones have poor aqueous solubility. 
Consequently, limited absorption and poor 
solubility pose major challenges in delivering 
medically effective concentrations of apigenin. To 
overcome these limitations, our group developed 
a targeted designed functional whole food from 
celery leaves, a rich source of apigenin, named 
CEBAR (CElery Based Apigenin Rich). We 
demonstrated that CEBAR efficiently increased 
the intake of apigenin enabled by the removal of 
glycosides. Here, we describe a method that 
optimized the process by reducing the saltiness 
without affecting the efficiency of apigenin 
deglycosylation resulting in an improved CEBAR 
formulation. We show that decreasing the 
concentration of phosphoric acid during acid 
hydrolysis aided the lowered use of potassium 
hydroxide needed for neutralization. These 
studies resulted in lessened saltiness while 
acquiring adequate levels of apigenin aglycone. 
Together, these findings would contribute to the 
implementation of targeted designed whole foods 
to deliver bioactive concentrations of apigenin 
and similar flavonoids and thus expanding the 
opportunities to prevent and treat inflammatory 
diseases.  
INTRODUCTION 
Flavonoids, one of the most abundantly found 
phytochemicals, are well-recognized medicinally 
active compounds or nutraceuticals known for their 
health-beneficial activities (Sudhakaran et al., 2019). 
Flavonoids are classified into different groups, 
including flavones, based on their structural and 
chemical modifications (Jiang et al., 2016). 
Apigenin, a flavone present at high levels in 
components of the Mediterranean diet, is a bioactive 
compound exerting antioxidant, anti-inflammatory 
and anti-cancer activities in cellular and in vivo 
models (Cardenas et al., 2016; Gao et al., 2013; Li et 
al., 2018; Nicholas et al., 2007). We recently showed 
that apigenin can be used as an adjuvant therapy to 
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enhance the efficacy of the chemotherapeutic drug 
doxorubicin in inducing apoptosis in three-
dimensional cultures of triple-negative breast cancer 
cells (Sudhakaran et al., 2020). Meta-analyses have 
reported a significant correlation between flavone 
intake and reduced breast cancer in both pre- and 
post-menopausal women (Bosetti et al., 2005; Hui et 
al., 2013). Hence, flavones represent an untapped 
clinical arsenal for the prevention and treatment of 
inflammatory diseases. However, poor aqueous 
solubility of flavones presents a major obstacle to 
efficiently delivering effective concentrations of 
these active compounds in a clinical setup. Thus, 
delivering bioactive concentrations of flavones 
through functional or medical foods has gained great 
attention.  
In plants, apigenin, like other flavonoids, is 
generally found as glycosides (Manach et al., 2004). 
Studies using mammalian cell culture and in vivo 
animal models revealed that flavone glycosides are 
less bioavailable compared to their aglycone 
counterparts (Ahn-Jarvis et al., 2019; Liu and Hu, 
2002). Previously, we showed that the lack of anti-
inflammatory activity of apigenin-7-O-glucoside in 
macrophages is due to its limited absorption 
compared with its aglycone counterpart (Hostetler et 
al., 2012). We also found that the reduced absorption 
of apigenin-7-O-glucoside resulted in diminished 
anti-cancer activity (Sudhakaran et al., 2020). In 
order to increase the delivery of apigenin at bioactive 
concentrations, we developed a targeted designed 
whole food from celery leaves, a rich source of 
apigenin, named CEBAR (CElery Based Apigenin 
Rich) (Hostetler et al., 2012). We demonstrated 
efficient bioactivity of the CEBAR diet, capable of 
delivering up to 1 μM apigenin, as an anti-
inflammatory agent in vivo in a mouse model by 
reducing the levels of proinflammatory cytokines 
and microRNAs at specific inflammatory sites 
(Arango et al., 2015; Cardenas et al., 2016; Hostetler 
et al., 2012). The targeted design of CEBAR 
successfully increased the intake of apigenin by 
relying on the removal of glycosides (Hostetler et al., 
2012). Here, we demonstrate a process that 
diminished CEBAR saltiness while maintaining the 
efficiency of apigenin deglycosylation, thereby 
improving the formulation. Our findings show that 
lowering the concentration of phosphoric acid 
(H3PO4) during the acid hydrolysis step facilitated 
the reduced use of potassium hydroxide (KOH), thus 
resulting in less saltiness while reaching equal 
success in the levels of apigenin aglycone obtained. 
These findings will have a beneficial impact by 
improving palatability, food tolerability, and 
broadening the inclusion of participants in future 
clinical studies using whole food flavone-rich diets. 
MATERIALS AND METHODS 
Deglycosylation of flavones.  Apigenin-7-O-
glucoside (Sigma, USA) 80 µM was treated with 
0.04 U/mL almond b-glucosidase (Sigma, USA) in 
0.08 M sodium acetate at varying pH and incubated 
at 37°C for 60 min. Samples were then extracted 
three times with diethyl ether and subsequently 
pooled. To obtain apigenin aglycone from celery, 
fresh celery leaves (Apium graveolens L., Apiaceae) 
were juiced, lyophilized and ground to a powder as 
we previously described (Hostetler et al., 2012). One 
gram of celery powder was incubated at 95-100°C in 
the presence of H3PO4 (Duda Energy, USA) at 
varying concentrations for 90 min. After acid 
hydrolysis, samples were cooled and neutralized to 
the desired pH with 20% KOH (Duda Energy, USA). 
The samples were then incubated with 170 mg of 
ground raw almonds (Prunus dulcis Mill., Rosaceae) 
at 50°C for 2 h to induce deglycosylation. Samples 
were then frozen overnight and subsequently 
lyophilized and ground to a fine powder with a 
mortar and pestle. At this point, the celery is referred 
to as the Celery Finished Product (CFP). CFP was 
extracted three times with 70% methanol for 30 min, 
centrifuged, and the supernatants were pooled. The 
pooled extractions were subsequently dried under N2 
stream and resuspended in 0.5 mL of 70% (v/v) 
methanol for HPLC analyses.  
Chemical analysis of flavones.  Flavone 
concentration in each sample was quantified using an 
Acquity UPLC BEH C18 column (2.1 × 50 mm, 1.7 
μm), and the specific flavonoids were detected using 
an Acquity triple quadrupole mass spectrometer 
(Waters, USA) with a dwell time of 36 ms. The 
analyses were done with 0.1% formic acid (solvent 
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A) and 0.1% formic acid in acetonitrile (solvent B) 
at a flow rate of 0.4 mL/min with the following 
gradient: time t=0, 99% solvent A; t=0.5 min, 99% 
solvent A; t=2.5 min, 50% solvent A; t=3.0 min, 0% 
solvent A; t=4.0 min, 0% solvent A; t=4.01 min, 99% 
solvent A; t=5.0 min, 99% solvent A. Source 
parameters included: capillary voltage of 1.0 kV in 
negative mode, cone 50 V, source block 130°C, 
desolvation 350°C, desolvation gas 800 L/h, cone 
gas 20 L/h, and collision gas 0.16 mL/min. The 
concentrations of flavones were calculated against a 
standard curve generated using commercially 
available pure apigenin, luteolin, chrysoeriol, 
apigenin-7-O-glucoside, luteolin-7-O-glucoside and 
apiin (Sigma, USA). The data was analyzed and 
integrated using MassLynx 4.1 software and the 
chromatograms were plotted using GraphPad Prism 
software. The percentage of apigenin derived from 
apigenin-7-O-glucoside is calculated as the amount 
of apigenin to that of apigenin-7-O-glucoside. 
Apigenin derivatives account for apigenin, apiin and 
apigenin-7-O-glucoside.  
Statistical analyses.  Graph and chromatogram 
preparation and statistical analyses were performed 
using GraphPad Prism software. Statistical 
differences between data were measured using a one-
way or two-way ANOVA and Turkey’s post-test for 
multiple comparisons. Data is presented mean ± 
SEM. p value greater than 0.05 is considered 
statistically insignificant. 
RESULTS 
Deglycosylation of apigenin-7-O-glucoside in 
celery extracts is limited by pH conditions.  We 
previously showed that celery leaves contain high 
levels of apigenin glycosides occurring as apigenin-
7-apisoylglucoside or apiin (Hostetler et al., 2012) 
(Figure 1). We demonstrated that converting flavone 
glycosides to aglycones increased their absorption in 
cells and in vivo in mouse models (Hostetler et al., 
2012). For the preparation of CEBAR, apiin is first 
converted to apigenin-7-O-glucoside by heating the 
celery leaves at acidic pH conditions in the presence 
of 1.5N H3PO4 (Figure 1). The removal of glycoside 
groups from apigenin-7-O-glucoside through the 
process deglycosylation is then achieved by 
treatment with the enzyme β-glucosidase at pH 5 
(Hostetler et al., 2012).  
 
Figure 1. Conversion of celery apiin to apigenin. Apiin 
present in celery leaves is subjected to acid hydrolysis to 
generate apigenin-7-O-glucoside. After neutralization, 
apigenin-7-O-glucoside is deglycosylated to apigenin using 
ground raw almond powder containing β-glucosidase.  
Intending to reduce the salt necessary to reach an 
optimal pH for the deglycosylation step, we first 
evaluated the optimal range of pH required for 
converting apigenin-7-O-glucoside to its aglycone 
counterpart, apigenin. For this purpose, 
commercially available pure apigenin-7-O-glucoside 
was incubated in the presence of β-glucosidase 
enzyme at various pH ranging from 5 to 4. No 
significant changes in the percentage of apigenin 
obtained were observed at all the pH tested, as shown 
by the quantitative chemical analyses performed 
(Figure 2).  
We next tested the possibility to use a pH lower 
than 5 to deglycosylate apigenin-7-O-glucoside to 
apigenin in celery extracts. In agreement with our 
previous findings (Hostetler et al., 2012), apigenin-
7-O-glucoside found in celery leaves extracts (Figure 
3C) can be deglycosylated by incubating β-
glucosidase found naturally in raw almond powder at 
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pH 5 for 2 h (Figure 3D). Increasing the incubation 
times to 4 or 6 h had no significant effect on the 
efficiency of deglycosylation at pH 5 (Figure 3E and 
F). 
 
Figure 2. Effect of pH on deglycosylation of apigenin-7-O-
glucoside using purified β-glucosidase. Pure apigenin-7-O-
glucoside was deglycosylated using purified almond β-
glucosidase at indicated pH at 37ºC for 60 min. Extracted 
apigenin and apigenin-7-O-glucoside were detected by 
HPLC analyses as described in Material and Methods. All 
data represent mean ± SEM, N = 3. ns indicates no statistical 
significance. 
 In order to decrease the amount of salt needed to 
adjust the pH required for the deglycosylation step, 
we next evaluated the effectiveness of performing 
the deglycosylation at pH 4. The chemical analyses 
of apigenin flavones showed that the amount of 
apigenin-7-O-glucoside converted to apigenin 
decreased at pH 4 as compared to the deglycosylation 
at pH 5 at incubations times of either 4 or 6 h, as 
depicted in the chromatograms (Figure 3G and H). 
There was a 50% decrease in the amount of apigenin 
aglycone generated at pH 4 as compared to pH 5. 
Overall, these results indicate that in contrast to the 
ability of the pure β-glucosidase enzyme to 
effectively deglycosylate apigenin-7-O-glucoside at 
a broader pH range, the deglycosylation of naturally 
occurring apigenin-7-O-glucoside in celery leaves 
extracts is favored by more restrictive pH conditions.  
Reduced concentration of phosphoric acid 
results in improved salt conditions.  Since regulating 
pH conditions proved to have less effect on 
deglycosylation, we decided to evaluate next if 
changes in the acid hydrolysis, wherein apiin is 
converted to apigenin-7-O-glucoside (Figure 4A), 
will facilitate the reduction of saltiness.  
Figure 3. Effect of pH on deglycosylation of celery apigenin-
7-O-glucoside using raw almond powder a source of β-
glucosidase. HPLC chromatograms of (A and B) flavone 
standards, celery extracts (C) before deglycosylation, post-
deglycosylation using almond β-glucosidase at (D-F) pH 5 
and (G and H) pH 4 at indicated times. Peaks represent: 1. 
Apigenin-7-O-glucoside and 2. Apigenin. 
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To this end, we evaluated the effect of different 
concentrations of H3PO4 on the efficacy of acid 
hydrolysis and subsequent deglycosylation by 
evaluating first the levels of apigenin derivatives 
(apiin and apigenin-7-O-glucoside and apigenin) at 
two concentrations of H3PO4. We found that 
decreasing the concentration of H3PO4 to 0.75N from 
1.5N did not have any significant effect on the acid 
hydrolysis, as indicated by the similar levels of 
apigenin-7-O-glucoside obtained from the 
hydrolysis of apiin at both the concentrations tested 
(Figure 4B). The decreased concentration of H3PO4 
lowered the amounts of KOH required to neutralize 
and reach the pH 5 optimal for deglycosylation. 
There was almost a decrease of 50% in the amount 
of KOH used for neutralization when the 
concentration of H3PO4 was reduced to 0.75N. 
Importantly, we found that the deglycosylation 
following these new conditions generated similar 
levels of apigenin aglycone (Figure 4B). These 
results demonstrate that the reduction of H3PO4 
concentration combined with less salt content 
resulted in a favorable deglycosylation of apigenin in 
CFP. 
 
Figure 4. Effect of phosphoric acid concentration on acid hydrolysis and deglycosylation of flavones in celery leaf extracts. (A) 
Flowchart of experimental design. Celery extracts were subjected to acid hydrolysis at the indicated phosphoric acid 
concentrations and deglycosylated using almond β-glucosidase at pH 5 for 2 h. (B) Extracted apigenin derivatives were detected 
by HPLC analyses. All data represent mean ± SEM, N = 3. ns indicates no statistical significance. 
 
DISCUSSION 
Bioactive compounds such as flavonoids are 
gaining immense interests as nutraceuticals for the 
prevention and treatment of inflammatory diseases. 
The delivery of flavonoids at medically effective 
concentrations in vivo is critical for its efficacy. 
However, flavones are associated with poor aqueous 
solubility, thereby affecting efficient delivery in 
vivo. Additionally, plant flavones are commonly 
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found in plants as glycosides which have restricted 
cellular absorption compared to their aglycones 
counterparts. Therefore, poor solubility and 
absorption of flavonoids present a major obstacle for 
their biomedical applications. The use of flavonoid-
rich whole foods for effective delivery presents 
favorable opportunities (Ahn-Jarvis et al., 2019). We 
previously developed a targeted designed whole food 
from celery leaves rich in flavone apigenin, named 
CEBAR, which exhibited effective bioactivity as an 
anti-inflammatory agent in mouse models (Arango et 
al., 2015; Cardenas et al., 2016; Hostetler et al., 
2012). Here, we reveal an efficient method to 
improve CEBAR formulations by reducing the 
saltiness of the preparation without affecting the 
efficacy of the deglycosylation of apigenin, thereby 
potentially improving its delivery and 
bioavailability.  
Apigenin is a bioactive flavone exhibiting anti-
cancer, anti-inflammatory and antioxidant activities 
(Salehi et al., 2019; Sudhakaran et al., 2019). Its 
ability to specifically target primary human cancer 
cells, without affecting cells from adjacent normal 
tissues, presents unique opportunities for clinical 
applications (Voss et al., 2021). We recently reported 
that apigenin sensitizes human breast cancer cells to 
chemotherapy by inducing apoptosis, thereby 
emphasizing its promising role as a 
chemotherapeutic adjuvant in a clinical set up 
(Sudhakaran et al., 2020). While the reported studies 
have confirmed health beneficial impacts of pure 
apigenin both in vitro and in vivo, it has been shown 
to have limited solubility, characteristic of 
flavonoids (Hollman, 2004). In most cellular models, 
the effective apigenin concentrations range between 
10 to 100 μM, amounts that are hard to achieve in 
vivo. Apigenin has limited bioavailability owing to 
its natural existence as a glycoside in plants, such as 
apiin and apigenin-7-O-glucosides (Jiang et al., 
2016). We and others have reported that flavone 
glycosides are less absorbed by cells than their 
aglycone counterparts. We demonstrated that 
apigenin-7-O-glucoside showed less cellular 
absorption compared to its aglycone counterpart 
using immunofluorescence, thereby exerting 
diminished anti-inflammatory and anti-cancer 
activity (Arango et al., 2015; Hostetler et al., 2012; 
Sudhakaran et al., 2020; Vargo et al., 2006). 
Additionally, apigenin in colorectal adenocarcinoma 
cells was highly permeable as compared to apigenin-
7-O-glucoside as indicated by HPLC analytical 
analyses (Liu and Hu, 2002). The flavone baicalin 
induces apoptosis in human breast cancer cells more 
effectively than its glycoside counterpart (Yu et al., 
2013). These differences in cellular absorption may 
be attributed to the planar structure of apigenin 
aglycone, which is conferred by the presence of a 
double bond between carbon 2 and 3 on the C ring. 
This planar structure contrasts with the change in the 
conformation of the structure due to the addition of 
the sugar in apigenin-7-O-glycoside. Underlining the 
impact of the structure on bioavailability in vivo, our 
previous studies showed that glycosylation 
diminished intestinal absorption of apigenin into 
systemic circulation in mice fed with celery-derived 
apigenin rich foods (Hostetler et al., 2012). These 
observations emphasize the need for designing food 
formulation that improve the delivery, solubility and 
bioavailability of apigenin and similar flavones to 
enhance their efficacy. 
Our apigenin rich celery food formulation 
CEBAR relies on hydrolysis of celery apiin to 
apigenin-7-O-glucoside followed by subsequent 
deglycosylation to apigenin to improve 
bioavailability (Hostetler et al., 2012). We 
previously showed that deglycosylation enhanced 
systemic circulation of apigenin in mice fed with 
CEBAR (Hostetler et al., 2012). In this study, we 
improved CEBAR formulations to reduce saltiness 
while maintaining the levels of deglycosylated 
apigenin. We initially chose to reduce the saltiness 
by optimizing pH conditions for deglycosylation 
using almond derived β-glucosidase. However, 
deglycosylation of apigenin-7-O-glucoside in celery 
leaves was found to be favored by a restricted pH 
range (Figure 4). Lowering H3PO4 concentration 
during acid hydrolysis of celery extract facilitated the 
decreased use of KOH. This enabled reduction in 
saltiness while generating adequate levels of 
apigenin aglycone through deglycosylation (Figure 
4B). This will help in enhancing apigenin absorption 
and confer higher bioavailability.  
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Several other studies have reported the use of 
whole food enriched with flavonoids to treat cancer 
in in vivo mice models. A whole food-based 
approach using freeze-dried berries and berry 
extracts inhibited rodent esophagus and colon cancer 
by more than 50% through DNA damage and 
apoptosis (Stoner et al., 2007; Wang et al., 2011). 
Dietary grape powder attenuated UVB-mediated 
skin carcinogenesis in SKH-1 hairless mouse model 
(Singh et al., 2019). There is a limited number of 
clinical studies for cancer and inflammatory diseases 
using flavonoid rich whole foods. Dietary black 
freeze-dried black raspberry intervention in 28 
colorectal cancer patients showed beneficial anti-
cancer activities by inducing metabolic changes (Pan 
et al., 2015). A pilot study involving patients with 
biopsy-confirmed oral squamous cell carcinomas 
administered with oral troches containing freeze-
dried black raspberry powder reported that the 
bioactive compounds were efficiently delivered to 
the affected sites and reduced the expression of anti-
apoptotic and anti-inflammatory markers. However, 
the study reported an adverse experience in three 
participants (Knobloch et al., 2016). Nonetheless, 
these studies highlight the importance of targeted 
whole foods to overcome the limitations of 
delivering pure flavonoids and reaching effective 
bioactive concentrations. 
In conclusion, CEBAR offers a promising 
targeted designed whole food formulation that can 
deliver effective biomedical concentrations of 
medicinally active apigenin. Our improved food 
formulations have efficient deglycosylation of celery 
apigenin while reducing the salt content. These 
findings may have profound implications by 
improving food tolerability and enhancing the 
potential use of CEBAR as whole food flavone-rich 
adjuvants to currently available standard of care. 
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